Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. (LALPATHLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
lalpathlabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹1925.20
Market cap
32,150 Cr
Stock P/E
66.2
P/B
12.65
Dividend yield
0.7%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 601 Cr | 539 Cr | 545 Cr | 602 Cr | 660 Cr | 597 Cr | 603 Cr | 670 Cr | 731 Cr | 660 Cr | 703 Cr | 798 Cr |
| Operating expenses (approx.) | 423 Cr | 398 Cr | 401 Cr | 432 Cr | 458 Cr | 443 Cr | 434 Cr | 477 Cr | 507 Cr | 480 Cr | 516 Cr | 550 Cr |
| EBITDA | 178 Cr | 141 Cr | 145 Cr | 170 Cr | 203 Cr | 154 Cr | 169 Cr | 192 Cr | 224 Cr | 179 Cr | 187 Cr | 248 Cr |
| OPM % | 29.6% | 26.1% | 26.5% | 28.2% | 30.7% | 25.8% | 28.0% | 28.7% | 30.7% | 27.2% | 26.6% | 31.0% |
| Other income | 18 Cr | 18 Cr | 18 Cr | 21 Cr | 22 Cr | 25 Cr | 26 Cr | 28 Cr | 25 Cr | 24 Cr | 24 Cr | 32 Cr |
| Interest | 8 Cr | 7 Cr | 7 Cr | 6 Cr | 6 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 7 Cr | 6 Cr | 6 Cr |
| Depreciation | 36 Cr | 36 Cr | 37 Cr | 35 Cr | 35 Cr | 36 Cr | 36 Cr | 35 Cr | 41 Cr | 42 Cr | 45 Cr | 44 Cr |
| Profit before tax | 152 Cr | 116 Cr | 120 Cr | 150 Cr | 183 Cr | 138 Cr | 153 Cr | 181 Cr | 204 Cr | 124 Cr | 160 Cr | 229 Cr |
| Tax % | 27.3% | 29.1% | 28.4% | 28.1% | 28.6% | 29.1% | -1.4% | 26.0% | 25.2% | 26.5% | 17.4% | 25.4% |
| Net profit | 111 Cr | 82 Cr | 86 Cr | 108 Cr | 131 Cr | 98 Cr | 156 Cr | 134 Cr | 152 Cr | 91 Cr | 132 Cr | 171 Cr |
| EPS (₹) | ₹13.16 | ₹9.77 | ₹10.13 | ₹12.79 | ₹15.52 | ₹11.60 | ₹18.57 | ₹15.88 | ₹18.05 | ₹5.42 | ₹7.86 | ₹10.15 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,203 Cr | 1,330 Cr | 1,581 Cr | 2,087 Cr | 2,017 Cr | 2,227 Cr | 2,461 Cr | 2,763 Cr | Sign in for TTM |
| Operating expenses (approx.) | 910 Cr | 987 Cr | 1,145 Cr | 1,527 Cr | 1,527 Cr | 1,617 Cr | 1,766 Cr | 1,980 Cr | Sign in for TTM |
| EBITDA | 294 Cr | 344 Cr | 436 Cr | 561 Cr | 490 Cr | 609 Cr | 696 Cr | 783 Cr | Sign in for TTM |
| OPM % | 24.4% | 25.8% | 27.6% | 26.9% | 24.3% | 27.4% | 28.3% | 28.3% | Sign in for TTM |
| Other income | 46 Cr | 55 Cr | 51 Cr | 53 Cr | 42 Cr | 69 Cr | 93 Cr | 101 Cr | Sign in for TTM |
| Interest | 0.80 Cr | 15 Cr | 16 Cr | 30 Cr | 38 Cr | 29 Cr | 22 Cr | 23 Cr | Sign in for TTM |
| Depreciation | 38 Cr | 73 Cr | 77 Cr | 108 Cr | 150 Cr | 144 Cr | 142 Cr | 162 Cr | Sign in for TTM |
| Profit before tax | 301 Cr | 311 Cr | 394 Cr | 475 Cr | 344 Cr | 506 Cr | 625 Cr | 669 Cr | Sign in for TTM |
| Tax % | 33.3% | 26.7% | 24.8% | 26.2% | 29.9% | 28.3% | 21.2% | 23.8% | Sign in for TTM |
| Net profit | 201 Cr | 228 Cr | 297 Cr | 350 Cr | 241 Cr | 362 Cr | 492 Cr | 510 Cr | Sign in for TTM |
| EPS (₹) | ₹24.19 | ₹27.42 | ₹35.33 | ₹41.70 | ₹28.82 | ₹43.05 | ₹58.48 | ₹30.24 | Sign in for TTM |
| Dividend payout % | — | — | — | 33.3% | 42.7% | 55.5% | 42.1% | 43.7% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 83 Cr | 84 Cr | 84 Cr | 168 Cr |
| Reserves | 862 Cr | 950 Cr | 1,162 Cr | 1,425 Cr | 1,583 Cr | 1,766 Cr | 2,089 Cr | 2,341 Cr |
| Borrowings | — | — | 0.10 Cr | 346 Cr | 237 Cr | 83 Cr | — | — |
| Other liabilities | 140 Cr | 320 Cr | 385 Cr | 464 Cr | 449 Cr | 487 Cr | 510 Cr | 605 Cr |
| Total liabilities | 1,091 Cr | 1,374 Cr | 1,661 Cr | 2,353 Cr | 2,386 Cr | 2,456 Cr | 2,717 Cr | 3,146 Cr |
| Fixed assets (net) | 160 Cr | 292 Cr | 306 Cr | 415 Cr | 401 Cr | 343 Cr | 336 Cr | 484 Cr |
| CWIP | 3 Cr | 10 Cr | 6 Cr | 14 Cr | 3 Cr | 4 Cr | 4 Cr | 6 Cr |
| Investments | 185 Cr | 164 Cr | 59 Cr | 66 Cr | 150 Cr | 148 Cr | 360 Cr | 455 Cr |
| Loans & advances | 0.90 Cr | 0.90 Cr | 0.90 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr |
| Inventories | 29 Cr | 57 Cr | 43 Cr | 52 Cr | 34 Cr | 37 Cr | 36 Cr | 44 Cr |
| Trade receivables | 53 Cr | 51 Cr | 67 Cr | 85 Cr | 71 Cr | 77 Cr | 88 Cr | 111 Cr |
| Cash & bank | 129 Cr | 197 Cr | 244 Cr | 378 Cr | 264 Cr | 361 Cr | 293 Cr | 243 Cr |
| Other assets | 530 Cr | 602 Cr | 936 Cr | 1,341 Cr | 1,462 Cr | 1,485 Cr | 1,600 Cr | 1,802 Cr |
| Total assets | 1,091 Cr | 1,374 Cr | 1,661 Cr | 2,353 Cr | 2,386 Cr | 2,456 Cr | 2,717 Cr | 3,146 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 447 Cr | 456 Cr | 535 Cr | 569 Cr | 636 Cr |
| Cash from investing | — | — | — | -449 Cr | -287 Cr | -24 Cr | -303 Cr | -422 Cr |
| Cash from financing | — | — | — | 136 Cr | -283 Cr | -414 Cr | -334 Cr | -264 Cr |
| Net cash flow | — | — | — | 134 Cr | -114 Cr | 97 Cr | -68 Cr | -50 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -29 Cr | 411 Cr | 478 Cr | 515 Cr | 462 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 31.7% | 30.9% | 33.0% | 33.5% | 19.7% | 27.2% | 29.3% | 27.2% |
| ROE % | 22.8% | 21.1% | 23.4% | 22.9% | 14.1% | 19.0% | 22.1% | 19.9% |
| Debtor days | 16 | 14 | 15 | 15 | 13 | 13 | 13 | 15 |
| Inventory days | 40 | 70 | 39 | 38 | 28 | 30 | 27 | 30 |
| Days payable | 111 | 144 | 132 | 107 | 127 | 151 | 150 | 123 |
| Cash conversion cycle | -55 | -60 | -78 | -54 | -87 | -108 | -110 | -78 |
| Debt / equity | — | 0.00 | 0.0001 | 0.23 | 0.14 | 0.05 | — | — |
| Current ratio | 5.88 | 3.93 | 4.26 | 1.80 | 2.07 | 2.42 | 3.39 | 3.48 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 | -0.46 | -0.42 | -0.31 |
Compare with peers
Loading peers…